Status:
ACTIVE_NOT_RECRUITING
Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Eosinophilic Esophagitis
Eligibility:
All Genders
14+ years
Phase:
NA
Brief Summary
The goal of this study is to test the feasibility and the tolerability of a tethered spectrally encoded confocal microscopy (SECM) capsule and to use it to image the esophagus.
Detailed Description
96 participants including healthy volunteers, patients with a suspicion of having Eosinophilic Esophagitis (EoE) and patients with a current or prior clinical diagnosis of EoE will be recruited and as...
Eligibility Criteria
Inclusion
- Participant must be a healthy volunteer
- OR participant must have a suspicion of EoE
- OR participant must have a prior clinical suspicion of EoE
- Participant must be older than 14 years of age
- Participant must be able to give informed consent
Exclusion
- Participants with the inability to swallow pills and capsules.
- Esophageal fistula and/or esophageal strictures with a stricture diameter that is smaller than the diameter of the capsule.
- Participants with prior endoscopic ablation or resection treatment of Barrett's Esophagus (BE)
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT02202590
Start Date
October 1 2013
End Date
December 1 2028
Last Update
October 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General hospital
Boston, Massachusetts, United States, 02114